An evidence-based clinical guideline for the diagnosis and treatment of degenerative lumbar spondylolisthesis†
To access this article, please choose from the options below
FDA device/drug status: not applicable.
Author disclosures: WCW (consultant for Stryker; member of scientific advisory board at Intrinsic Therapeutics; receives remuneration from Blackstone Medical, Inc.); CMB (receives royalties from Life Spine; consultant for Depuy Spine and Medtronic Sofamor Danek; speaker for Depuy Spine and Stryker Spine; fellowship support from Depuy Spine; grant from Stryker Spine; member of board of directors at North American Spine Society; research support from Archus Orthopedics and Synthes Spine; receives financial support from Applied Spine); GG (receives royalties and consultant for Abbott Spine; stockholder at Allez Spine and DiFusion; speaker and travel support from Stryker Spine; member of scientific advisory board at DiFusion); MHH (royalties, stockholder, consultant, member of scientific advisory board at Relievant Medsystems; research support from Department of Defense); DSK (speaker and travel support from Smith & Nephew); CO (stockholder at Relievant and Nocimed; consultant for SpineView, ISTO, and Alleva; member of scientific advisory board at Relievant); DKR (consultant for medtronic); WOS (consultant for DePuy Spine; travel support from BrainLab; royalties from Depuy Spine).
PII: S1529-9430(09)00151-X
doi:10.1016/j.spinee.2009.03.016
© 2009 Elsevier Inc. All rights reserved.
